scispace - formally typeset
A

Anna Rita Bilia

Researcher at University of Florence

Publications -  310
Citations -  8996

Anna Rita Bilia is an academic researcher from University of Florence. The author has contributed to research in topics: Artemisinin & Artemisia annua. The author has an hindex of 45, co-authored 295 publications receiving 7487 citations. Previous affiliations of Anna Rita Bilia include University of Pisa.

Papers
More filters
Journal ArticleDOI

Essential Oils Loaded in Nanosystems: A Developing Strategy for a Successful Therapeutic Approach

TL;DR: Nanocarriers can be proposed: polymeric nanoparticulate formulations, extensively studied with significant improvement of the essential oil antimicrobial activity, and lipid carriers, including liposomes, solid lipid nanoparticles, nanostructured lipid particles, and nano- and microemulsions.
Journal ArticleDOI

Hypericins as potential leads for new therapeutics.

TL;DR: The aim of this review is to analyse the most recent advances in the chemistry and biological activities (in vitro and in vivo) of the pure naphthodianthrones, hypericin and pseudohypericin from H. perforatum.
Journal ArticleDOI

Anti-inflammatory activity of unusual lupane saponins from Bupleurum fruticescens

TL;DR: Extracts from Bupleurum fruticescens were examined for oral and topical anti-inflammatory activities and the BuOH extract proved to be active against carrageenan and tetradecanoylphorbol acetate acute edemas and allowed the isolation of three saponins identified by spectroscopic techniques.
Journal ArticleDOI

St. John's wort and depression: Efficacy, safety and tolerability-an update

TL;DR: St. John's wort (Hypericum perforatum L.) is a medicinal plant traditionally used, both externally and internally, in all Europe for many pathologies as discussed by the authors.
Journal ArticleDOI

Kaempferol derivatives as antiviral drugs against the 3a channel protein of coronavirus.

TL;DR: It is suggested that viral ion channels, in general, may be a good target for the development of antiviral agents, and that kaempferol glycosides are good candidates for 3a channel proteins of coronaviruses.